Ciprofloxacin-resistant Salmonella enterica serotype Typhimurium, China.
We characterized 44 Salmonella enterica serotype Typhimurium isolates from Tongji Hospital outpatients in Wuhan, China, May 2002-October 2005. All 31 ciprofloxacin-resistant isolates were also resistant to > or = 8 other antimicrobial drugs and carried > or = 2 mutations in GyrA and 1 mutation in ParC. Class 1 integrons were identified in 37 isolates.
Cui
Shenghui
S
State Food and Drug Administration, Beijing, People's Republic of China.
Li
Jingyun
J
Sun
Ziyong
Z
Hu
Changqin
C
Jin
Shaohong
S
Guo
Yunchang
Y
Ran
Lu
L
Ma
Yue
Y
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002681:China / Q000453:epidemiology; D002939:Ciprofloxacin / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D005243:Feces / Q000382:microbiology; D006801:Humans; D012480:Salmonella Infections / Q000453:epidemiology / Q000382:microbiology*; D012486:Salmonella typhimurium / Q000187:drug effects*; D018571:Sentinel Surveillance
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin